Hot Biotech Trades for Second-Half 2011

Description:

According to Adam Feuerstein, these biotech trades "encompass pending FDA drug approval decisions and clinical trial results -- all of which have the potential to produce significant stock-price volatility in the next six months." Read more here.

>>Also: 3 Funds' Best Stock Picks Ahead of Earnings

>>Also: 7 Best-Performing Dow Stocks

Most Viewed Portfolios

View All

Articles

4 Tech Stocks Under $10 Spiking Higher

05.23.13 | 02:46 PM

MADISON, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage...

3 Big Stocks on Traders' Radars

05.23.13 | 02:50 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of gen...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter